Supreme Court in Actavis: analyse reverse-payment settlements' anticompetitive effects case by case
In a much-anticipated decision, the Supreme Court in FTC v Actavis held 5−3 that reverse-payment settlements of Hatch-Waxman Act litigation are neither immune from antitrust liability nor presumptively unlawful, but rather must be analysed under the rule-of-reason standard on a case-by-case basis.
In choosing the traditional antitrust standard, the decision rejected all lower-court approaches to these settlements and resolved a split between the Third Circuit — which had held such agreements presumptively unlawful — and the Eleventh, Second and Federal Circuits, which essentially had immunised the agreements as long as they fell within the exclusionary scope of the underlying patent.
Acknowledging that application of the rule of reason might require antitrust trial courts in some cases to determine the validity of the underlying patent, the court stated that such an occurrence should be rare because the size of the reverse payment can function as a ‘workable surrogate for the patent’s weakness’ (Slip Op. 19). Thus, the court directed trial judges to weigh the anticompetitive effects of a particular reverse payment by reference to ‘its size, its scale in relation to the payor’s anticipated future litigation costs, its independence from other services for which it might represent payment and the lack of any other convincing justification’ (Slip Op. 20)…
If you are registered and logged in to the site, click on the link below to read the rest of the DLA Piper briefing. If not, please register or sign in with your details below.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
This is an Australian-specific alternative chapter on data protection, which was designed to assist organisations operating in Australia with their new privacy responsibilities.
Health Alert — Lane v Northern NSW Local Health District (No 3); Psychology Board of Australia v Tubara; and more
DLA Piper has released the 28 July 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
Analysis from The Lawyer
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions